Table 1.

Baseline uptake of preventive therapy among women with atypical hyperplasia/lobular cancer in situ enrolled in the high-risk breast cohort (n = 626), September, 2011–October, 2015

Preventive therapy
Yes (n = 279)No (n = 347)
Total n = 626n (%)n (%)P
Type of lesion
 Lobular carcinoma in situ11057 (51.8)53 (48.2)
 Atypical hyperplasia516222 (43.0)294 (57.0)0.11
Age
 ≤40304 (13.3)26 (86.7)
 41–5013663 (46.3)73 (53.7)
 51–60243106 (43.6)137 (56.4)
 >60217106 (48.8)111 (51.2)<0.01
Race/ethnicity
 Non-Hispanic White473222 (46.9)251 (53.1)
 Non-Hispanic Black4515 (33.3)30 (66.6)
 Asian288 (28.6)20 (71.4)
 Hispanic6128 (45.9)33 (54.1)
 Other196 (31.6)13 (68.4)0.21
Education status
 High school and below9041 (45.6)49 (54.4)
 Above high school536238 (44.4)298 (55.6)0.90
Marital status
 Married479218 (45.5)261 (54.5)
 Widowed3819 (50.0)19 (50.0)
 Divorced/separated8031 (38.7)49 (61.3)
 Never married2810 (35.7)18 (64.3)
 Missing11 (100.0)0 (0.0)0.46
Employment status
 Employed352163 (46.3)189 (53.7)
 Homemaker9137 (40.7)54 (59.3)
 Retired13966 (47.5)73 (52.5)
 Disabled/unemployed218 (38.1)13 (61.9)
 Student/other224 (18.2)18 (81.8)
 Missing11 (100.0)0 (0.0)0.08